Abstract
We have not added the abstract for this paper yet. The publisher's page has the full record.
Nilvadipine in mild to moderate Alzheimer disease: a randomised controlled trial
PLoS medicine · Vol. 15 Published January 1, 2018
More on these topics
Browse all publications →-
2026 · Alzheimers Dement.
Evaluating digital cognitive tests for clinical use in Alzheimer's disease: A novel framework and scoping review
-
2026 · Stat Med.
Time-Scale Target Parameters and Two-Step Estimation in Longitudinal Trials for Progressive Diseases
-
2026 · Nat Med
Target product profiles for treatments to delay or prevent symptomatic Alzheimer's disease
-
2026 · Alzheimers Dement
Biomarkers in patients with clinical signs of mild cognitive impairment or mild Alzheimer's disease but without amyloid deposits on positron emission tomography: Results from Bio-Hermes Study participants